Vascular diseases have high worldwide mortality, propelling advances in endovascular surgeries. Developing effective and long-term revascularization solutions has gathered immense attention among healthcare providers. Autologous arteries or veins as well as synthetic grafts have gained acceptance in the vascular grafts market. A key aim is to improve patency rates in such procedures. In this light, tissue-engineered vascular grafts are attracting attention and research interest among industry players. Though synthetic vascular prostheses have gained significant acceptance among the patient populations, some glaring limitations have hindered the commercialization scope of respective implant developers. Particularly, the marketplace hasn’t been so promising in regard to developing grafts for small-diameter vessels, which is less than 6 mm.

Autologous arteries or veins have emerged as the gold standards, but the failure rates in the last five years have alarmed researchers and proponents for tissue engineering. This has kicked in demand for in situ tissue engineering approaches. For such approaches to enter mainstream, the regulatory burden for clinical translation should be low. In this regard, cell-free scaffolds are showing some clinical potential. There are, however, several things to keep in focus for an adequate success rate, notably implant materials and subsequently the fabrication methods. Some of the common endpoints are hemocompatibility, an adequate microenvironment for tissue generation, and a good combination of elasticity and strength of the biomaterials. Perhaps the most important endpoint, which many players in the vascular grafts market have been pursuing, is overcoming compliance mismatch. In this regard, electrospinning is one of the widely used techniques of obtaining the graft. Several new approaches will shape the prospects of the market in coming months.

Though the body of research has been hindered by Covid-19 pandemic, which is still emerging, healthcare providers are optimistic of the rise in demand in the next few months. Moreover, several elective endovascular surgeries which might have been postponed might offer momentum in the times when the economies are opening with restrictions. Further, new vascular graft designs are likely to be tested in the market in not-so-distant future.

Global Vascular Grafts Market – Snapshot 

Vascular grafts are used to redirect blood flow from one part of the body to another by connecting blood vessels. Vascular grafting surgery is performed to treat ischemia caused by atherosclerosis, organ transplantation, or for vascular access in hemodialysis. However, demand for vascular grafts is anticipated to decline during the forecast period owing to increase in adverse effects like decellularized xenogeneic grafts increase the rate of infection, thrombosis, and aneurysms.

vascular grafts market

The global vascular grafts market was valued at US$ 2,010.1 Mn in 2017 and is projected to expand at a CAGR of 5.0% from 2018 to 2026 to reach US$ 3,000 Mn by 2026. High incidence rate of cardiovascular diseases, peripheral diseases, and rise in geriatric population are likely to fuel the growth of the global market from 2018 to 2026. Surge in government investment in health care infrastructure and strategic alliances among players to penetrate the emerging markets are expected to propel the global market during the forecast period.

In terms of product, the global vascular grafts market has been segmented into endovascular stent grafts, peripheral vascular grafts, hemodialysis access grafts, bypass grafts, and others. The endovascular stent grafts segment held the largest market share in 2017. Moreover, the segment is anticipated to expand at a high CAGR during the forecast period due to high demand for minimally invasive surgeries and rise in preference for stent grafts to treat atherosclerosis. Based on source, the global market has been classified into synthetic, biological, and biosynthetic. The synthetic segment is projected to dominate the global market during the forecast period owing to its good materialistic properties such as flexibility. In terms of size of vascular graft, the global vascular graft market has been bifurcated into large and small. The small segment is expected to expand at a high CAGR due to increase in focus of major players on the development of small size vascular grafts to treat narrow vascular atherosclerosis. Based on end-user, the global market has been divided into hospitals, ambulatory surgery centers, cardiac catheterization laboratories, specialty clinics, and others. The hospitals segment accounted for the largest market share in 2017. The segment is expected to expand at a significant CAGR during the forecast period. 

North America is projected to account for major share of the global vascular grafts market from 2018 to 2026, supported by rise in prevalence of cardiovascular diseases and increase in the number of vascular surgeries. According to the Journal of Vascular Surgery (2012), critical limb ischemia is associated with significant cost to the U.S. health care system and is estimated to exceed US$ 3 Bn annually. According to data provided by the American College of Cardiology, more than 130 million adults in the U.S. are anticipated to have some form of cardiovascular diseases (CVD) by 2035, and the total cost of CVD is expected to reach US$ 1.1 Trn in 2035. The vascular graft market in Asia Pacific is likely to expand at a high CAGR during the forecast period due to increase in focus on development of health care infrastructure by both public and private hospitals and high cardiovascular patient pool in countries such as India and China. 

Key companies operating in the global vascular grafts market and profiled in the report include W. L. Gore & Associates, Inc., Maquet Holding B.V. & Co. KG (Getinge Group), BD, LeMaitre Vascular, Inc., B. Braun Melsungen AG, Cook Medical, Medtronic plc, Artegraft, Inc., Vascutek Ltd., Vascular Graft Solution Ltd., Heat Medical Europe BV, and CryoLife, Inc.

Global Vascular Grafts Market: Overview 

Vascular grafts is a medical device that belongs to a specialized class of medical textiles. The primary purpose of a vascular grafts is to act as an artificial conduit for a diseased artery and help to redirect blood flow from one area to another. Presently, synthetic vascular Grafts are most commonly used which are made of either Dacron or Teflon. Increase in incidence of cardiovascular diseases and peripheral diseases is projected to drive demand for vascular grafts.

The global vascular grafts market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, source, size of vascular grafts, application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global vascular grafts market. 

Global Vascular Grafts Market: Key Segments

In terms of product, the global vascular grafts market has been segmented into endovascular stent grafts, peripheral vascular grafts, hemodialysis access grafts, bypass grafts, and others. In terms of source, the market has been classified into synthetic, biological, and biosynthetic. The synthetic segment has been categorized into polytetrafluethylene (PTFE), polyurethane (PU), Dacron, and others. The biological segment has been divided into bovine vein, saphenous vein, and others. The biosynthetic segment has been bifurcated into ovine collagen with polyester and others. In terms of size of vascular grafts, the global vascular grafts market has been classified into large and small. Based on application, the market has been categorized into coronary artery bypass, aneurysm, vascular occlusion, critical limb ischemia, renal failure, and others. Based on end-user, the global vascular grafts market has been divided into hospitals, ambulatory surgery centers, cardiac catheterization laboratories, specialty clinics, and others.

Global Vascular Grafts Market: Regional Outlook

Geographically, the global vascular grafts market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions. 

Companies Mentioned in Report

The report also profiles major players in the global vascular grafts market in terms of various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the report are W. L. Gore & Associates, Inc., Maquet Holding B.V. & Co.KG (Getinge Group), BD, LeMaitre Vascular, Inc., B. Braun Melsungen AG, Cook Medical, Medtronic plc, ArteGrafts, Inc., Vascutek Ltd., Vascular Grafts Solution Ltd., Heat Medical Europe BV, and CryoLife, Inc. 

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global vascular Grafts market has been segmented as follows:

Product

  • Endovascular Stent Grafts
  • Peripheral Vascular Grafts
  • Hemodialysis Access Grafts
  • Bypass Grafts
  • Others

Source

  • Synthetic
    • Polytetrafluethylene (PTFE)
    • Polyurethane (PU)
    • Dacron
    • Others
  • Biological
    • Bovine Vein
    • Saphenous Vein
    • Others
  • Biosynthetic
    • Ovine Collagen with Polyester
    • Others

Vascular Graft

  • Large
  • Small

 

Application

  • Coronary Artery Bypass
  • Aneurysm
  • Vascular Occlusion
  • Critical Limb Ischemia
  • Renal Failure
  • Others

End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
  • Specialty Clinics
  • Others

Region

  • North America
    • U.S.
    • Canada 
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe 
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific 
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America 
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights
     1.3. Assumptions and Acronyms Used

2. Research Methodology 

3. Executive Summary

4. Market Overview
     4.1. Introduction
     4.2. Key Industry Evolution/Developments
     4.3. Market Dynamics
            4.3.1. Drivers
                     4.3.1.1. Increase in the Incidence of Target Diseases 
                     4.3.1.2. Rise in the Number of Lifestyle-related Disorders
                     4.3.1.3. Increase in the Geriatric Population
                     4.3.1.4. Shift toward Value-based Health Care Model 
                     4.3.1.5. Increase in Health Care Spending & Improvement in Health Care Infrastructure
            4.3.2. Restraints
                     4.3.2.1. Stringent Regulatory Guidelines
                     4.3.2.2. Increase in Adverse Effects
                     4.3.2.3. Rise in Pricing Pressure
            4.3.3. Opportunities
                     4.3.3.1. Rise in Cases of Renal Impairment, Diabetes, and Obesity
                     4.3.3.2. Increase in the Number of Potential Markets for Commercializing Vascular Grafts
                     4.3.3.3. Anti-microbial Coated Grafts
     4.4. Global Vascular Market Analysis & Forecast, 2018–2026
                     4.4.1.1. Market Revenue Projections (US$ Mn)

5. Market Overview
     5.1. Global Prevalence of Chronic Kidney Diseases
     5.2. Global Prevalence of End-stage Renal Disorders (ESRD)
     5.3. Patient Data for Dialysis
     5.4. Global Prevalence of Cardiovascular Diseases
     5.5. Overview of Cryopreservation Technique
     5.6. Pipeline Analysis

6. Global Vascular Grafts Market, by Product 
     6.1. Introduction and Definitions 
     6.2. Key Findings
     6.3. Global Vascular Grafts Market Analysis, by Product 
     6.4. Global Vascular Grafts Market Forecast, by Product 
            6.4.1. Endovascular Stent Grafts
            6.4.2. Peripheral Vascular Grafts
            6.4.3. Hemodialysis Access Grafts
            6.4.4. Bypass Grafts
            6.4.5. Others 
     6.5. Global Vascular Grafts Market Attractiveness Analysis, by Product 

7. Global Vascular Grafts Market, by Source
     7.1. Introduction and Definitions 
     7.2. Key Findings
     7.3. Global Vascular Grafts Market Analysis, by Source
     7.4. Global Vascular Grafts Market Forecast, by Source
            7.4.1. Synthetic
                     7.4.1.1. Polytetrafluethylene (PTFE)
                     7.4.1.2. Polyurethane (PU)
                     7.4.1.3. Dacron
                     7.4.1.4. Others
            7.4.2. Biological 
                     7.4.2.1. Bovine Vein
                     7.4.2.2. Saphenous Vein
                     7.4.2.3. Others
            7.4.3. Biosynthetic
                     7.4.3.1. Ovine Collagen with Polyester
                     7.4.3.2. Others
     7.5. Global Vascular Grafts Market Attractiveness Analysis, by Source

8. Global Vascular Grafts Market Analysis and Forecast, by Size of Vascular Graft
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Global Vascular Grafts Market Analysis, by Size of Vascular Graft
     8.4. Global Vascular Grafts Market Value Forecast, by Size of Vascular Graft, 2016–2026 
            8.4.1. Large
            8.4.2. Small
     8.5. Global Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft

9. Global Vascular Grafts Market Analysis and Forecast, by Application
     9.1. Introduction & Definition
     9.2. Key Findings / Developments
     9.3. Global Vascular Grafts Market Analysis, by Application
     9.4. Global Vascular Grafts Market Value Forecast, by Application, 2016–2026 
            9.4.1. Coronary Artery Bypass
            9.4.2. Aneurysm
            9.4.3. Vascular Occlusion
            9.4.4. Critical Limb Ischemia
            9.4.5. Renal Failure
            9.4.6. Others
     9.5. Others Global Vascular Grafts Market Attractiveness Analysis, by Application

10. Global Vascular Grafts Market Analysis and Forecast, by End-user
     10.1. Introduction & Definition
     10.2. Key Findings / Developments
     10.3. Global Vascular Grafts Market Analysis, by End-user
     10.4. Global Vascular Grafts Market Value Forecast, by End-user, 2016–2026 
            10.4.1. Hospitals
            10.4.2. Ambulatory Surgical Centers
            10.4.3. Cardiac Catheterization Laboratories
            10.4.4. Specialty Clinics
            10.4.5. Others
            10.4.6. Others Global Vascular Grafts Market Attractiveness Analysis, by End-user

11. Global Vascular Grafts Market Analysis and Forecast, by Region
     11.1. Introduction & Definition
     11.2. Key Findings / Developments
     11.3. Market Value Forecast, by Region, 2016–2026 
            11.3.1. North America 
            11.3.2. Europe 
            11.3.3. Asia Pacific 
            11.3.4. Latin America
            11.3.5. Middle East & Africa 
     11.4. Global Vascular Grafts Attractiveness Analysis, by Region 

12. North America Vascular Grafts Market Analysis and Forecast, by Region
     12.1. Key Findings
     12.2. North America Vascular Grafts Market Overview
     12.3. North America Vascular Grafts Market Value Share Analysis, by Country
     12.4. North America Vascular Grafts Market Size and Forecast, by Country
            12.4.1. U.S.
            12.4.2. Canada
     12.5. North America Vascular Grafts Market Value Share Analysis, by Product
     12.6. North America Vascular Grafts Market Size and Forecast, by Product
            12.6.1. Endovascular Stent Grafts
            12.6.2. Peripheral Vascular Grafts
            12.6.3. Hemodialysis Access Grafts
            12.6.4. Bypass Grafts
            12.6.5. Others 
     12.7. North America Vascular Grafts Market Value Share Analysis, by Source
     12.8. North America Vascular Grafts Market Size and Forecast, by Source
            12.8.1. Synthetic
                     12.8.1.1. Polytetrafluethylene (PTFE)
                     12.8.1.2. Polyurethane (PU)
                     12.8.1.3. Dacron
                     12.8.1.4. Others
            12.8.2. Biological 
                     12.8.2.1. Bovine Vein
                     12.8.2.2. Saphenous Vein
                     12.8.2.3. Others
            12.8.3. Biosynthetic
                     12.8.3.1. Ovine Collagen with Polyester
                     12.8.3.2. Others
     12.9. North America Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft
     12.10. North America Vascular Grafts Market Size and Forecast, by Size of Vascular Graft
            12.10.1. Large
            12.10.2. Small
     12.11. North America Vascular Grafts Market Value Share Analysis, by Application
     12.12. North America Vascular Grafts Market Size and Forecast, by Application
            12.12.1. Coronary Artery Bypass
            12.12.2. Aneurysm
            12.12.3. Vascular Occlusion
            12.12.4. Critical Limb Ischemia
            12.12.5. Renal Failure
            12.12.6. Others
     12.13. North America Vascular Grafts Market Value Share Analysis, by End-User
     12.14. North America Vascular Grafts Market Size and Forecast, by End-user
            12.14.1. Hospitals
            12.14.2. Ambulatory Surgical Centers
            12.14.3. Cardiac Catheterization Laboratories
            12.14.4. Specialty Clinics
            12.14.5. Others
     12.15. North America Vascular Grafts Market Size and Forecast, by Market Attractiveness
            12.15.1. Product 
            12.15.2. Source
            12.15.3. Size of Vascular Graft
            12.15.4. Application
            12.15.5. End-user
            12.15.6. Country 

13. Europe Vascular Grafts Market Analysis and Forecast, by Region
     13.1. Key Findings
     13.2. Europe Vascular Grafts Market Overview
     13.3. Europe Vascular Grafts Market Value Share Analysis, by Country/Sub-region
     13.4. Europe Vascular Grafts Market Size and Forecast, by Country/Sub-region
            13.4.1. Germany
            13.4.2. France
            13.4.3. U.K.
            13.4.4. Spain
            13.4.5. Italy
            13.4.6. Rest of Europe
     13.5. Europe Vascular Grafts Market Value Share Analysis, by Product     
     13.6. Europe Vascular Grafts Market Size and Forecast, by Product
            13.6.1. Endovascular Stent Grafts
            13.6.2. Peripheral Vascular Grafts
            13.6.3. Hemodialysis Access Grafts
            13.6.4. Bypass Grafts
            13.6.5. Others 
     13.7. Europe Vascular Grafts Market Value Share Analysis, by Source
     13.8. Europe Vascular Grafts Market Size and Forecast, by Source
            13.8.1. Synthetic
                     13.8.1.1. Polytetrafluethylene (PTFE)
                     13.8.1.2. Polyurethane (PU)
                     13.8.1.3. Dacron
                     13.8.1.4. Others
            13.8.2. Biological 
                     13.8.2.1. Bovine Vein
                     13.8.2.2. Saphenous Vein
                     13.8.2.3. Others
            13.8.3. Biosynthetic
                     13.8.3.1. Ovine Collagen with Polyester
                     13.8.3.2. Others
     13.9. Europe Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft
     13.10. Europe Vascular Grafts Market Size and Forecast, by Size of Vascular Graft
            13.10.1. Large
            13.10.2. Small
     13.11. Europe Vascular Grafts Market Value Share Analysis, by Application
     13.12. Europe Vascular Grafts Market Size and Forecast, by Application
            13.12.1. Coronary Artery Bypass
            13.12.2. Aneurysm
            13.12.3. Vascular Occlusion
            13.12.4. Critical Limb Ischemia
            13.12.5. Renal Failure
            13.12.6. Others
     13.13. Europe Vascular Grafts Market Value Share Analysis, by End-User
     13.14. Europe Vascular Grafts Market Size and Forecast, by End-user
            13.14.1. Hospitals
            13.14.2. Ambulatory Surgical Centers
            13.14.3. Cardiac Catheterization Laboratories
            13.14.4. Specialty Clinics
            13.14.5. Others
     13.15. Europe Vascular Grafts Market Size and Forecast, by Market Attractiveness
            13.15.1. Product 
            13.15.2. Source
            13.15.3. Size of Vascular Graft
            13.15.4. Application
            13.15.5. End-user
            13.15.6. Country 

14. Asia Pacific Vascular Grafts Market Analysis and Forecast, by Region
     14.1. Key Findings
     14.2. Asia Pacific Vascular Grafts Market Overview
     14.3. Asia Pacific Vascular Grafts Market Value Share Analysis, by Country/Sub-region
     14.4. Asia Pacific Vascular Grafts Market Size and Forecast, by Country/Sub-region
            14.4.1. China
            14.4.2. Japan
            14.4.3. India
            14.4.4. Australia & New Zealand
            14.4.5. Rest of Asia Pacific 
     14.5. Asia Pacific Vascular Grafts Market Value Share Analysis, by Product 
     14.6. Asia Pacific Vascular Grafts Market Size and Forecast, by Product 
            14.6.1. Endovascular Stent Grafts
            14.6.2. Peripheral Vascular Grafts
            14.6.3. Hemodialysis Access Grafts
            14.6.4. Bypass Grafts
            14.6.5. Others 
     14.7. Asia Pacific Vascular Grafts Market Value Share Analysis, by Source
     14.8. Asia Pacific Vascular Grafts Market Size and Forecast, by Source
            14.8.1. Synthetic
                     14.8.1.1. Polytetrafluethylene (PTFE)
                     14.8.1.2. Polyurethane (PU)
                     14.8.1.3. Dacron
                     14.8.1.4. Others
            14.8.2. Biological 
                     14.8.2.1. Bovine Vein
                     14.8.2.2. Saphenous Vein
                     14.8.2.3. Others
            14.8.3. Biosynthetic
                     14.8.3.1. Ovine Collagen with Polyester
                     14.8.3.2. Others
     14.9. Asia Pacific Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft
     14.10. Asia Pacific Vascular Grafts Market Size and Forecast, by Size of Vascular Graft
            14.10.1. Large
            14.10.2. Small
     14.11. Asia Pacific Vascular Grafts Market Value Share Analysis, by Application
     14.12. Asia Pacific Vascular Grafts Market Size and Forecast, by Application
            14.12.1. Coronary Artery Bypass
            14.12.2. Aneurysm
            14.12.3. Vascular Occlusion
            14.12.4. Critical Limb Ischemia
            14.12.5. Renal Failure
            14.12.6. Others
     14.13. Asia Pacific Vascular Grafts Market Value Share Analysis, by Application
     14.14. Asia Pacific Vascular Grafts Market Size and Forecast, by Application
            14.14.1. Hospitals
            14.14.2. Ambulatory Surgical Centers
            14.14.3. Cardiac Catheterization Laboratories
            14.14.4. Specialty Clinics
            14.14.5. Others
     14.15. Asia Pacific Vascular Grafts Market Size and Forecast, by Market Attractiveness
            14.15.1. Product 
            14.15.2. Source
            14.15.3. Size of Vascular Graft
            14.15.4. Application
            14.15.5. End-user
            14.15.6. Country/Sub-region

15. Latin America Vascular Grafts Market Analysis and Forecast, by Region
     15.1. Key Findings
     15.2. Latin America Vascular Grafts Market Overview
     15.3. Latin America Vascular Grafts Market Value Share Analysis, by Country/Sub-region
     15.4. Latin America Vascular Grafts Market Size and Forecast, by Country/Sub-region
            15.4.1. Brazil
            15.4.2. Mexico
            15.4.3. Rest of Latin America 
     15.5. Latin America Vascular Grafts Market Value Share Analysis, by Product 
     15.6. Latin America Vascular Grafts Market Size and Forecast, by Product 
            15.6.1. Endovascular Stent Grafts
            15.6.2. Peripheral Vascular Grafts
            15.6.3. Hemodialysis Access Grafts
            15.6.4. Bypass Grafts
            15.6.5. Others 
     15.7. Latin America Vascular Grafts Market Value Share Analysis, by Source
     15.8. Latin America Vascular Grafts Market Size and Forecast, by Source
            15.8.1. Synthetic
                     15.8.1.1. Polytetrafluethylene (PTFE)
                     15.8.1.2. Polyurethane (PU)
                     15.8.1.3. Dacron
                     15.8.1.4. Others
            15.8.2. Biological 
                     15.8.2.1. Bovine Vein
                     15.8.2.2. Saphenous Vein
                     15.8.2.3. Others
            15.8.3. Biosynthetic
                     15.8.3.1. Ovine Collagen with Polyester
                     15.8.3.2. Others
     15.9. Latin America Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft
     15.10. Latin America Vascular Grafts Market Size and Forecast, by Size of Vascular Graft
            15.10.1. Large
            15.10.2. Small
     15.11. Latin America Vascular Grafts Market Value Share Analysis, by Application
     15.12. Latin America Vascular Grafts Market Size and Forecast, by Application
            15.12.1. Coronary Artery Bypass
            15.12.2. Aneurysm
            15.12.3. Vascular Occlusion
            15.12.4. Critical Limb Ischemia
            15.12.5. Renal Failure
            15.12.6. Others
     15.13. Latin America Vascular Grafts Market Value Share Analysis, by End-user
     15.14. Latin America Vascular Grafts Market Size and Forecast, by End-user
            15.14.1. Hospitals
            15.14.2. Ambulatory Surgical Centers
            15.14.3. Cardiac Catheterization Laboratories
            15.14.4. Specialty Clinics
            15.14.5. Others 
     15.15. Latin America Vascular Grafts Market Size and Forecast, by Market Attractiveness
            15.15.1. Product 
            15.15.2. Source
            15.15.3. Size of Vascular Graft
            15.15.4. Application
            15.15.5. End-user
            15.15.6. Country/Sub-region

16. Middle East & Africa Vascular Grafts Market Analysis and Forecast, by Region
     16.1. Key Findings
     16.2. Middle East & Africa Vascular Grafts Market Overview
     16.3. Middle East & Africa Vascular Grafts Market Value Share Analysis, by Country/Sub-region
     16.4. Middle East & Africa Vascular Grafts Market Size and Forecast, by Country/Sub-region
            16.4.1. GCC Countries
            16.4.2. South Africa
            16.4.3. Rest of Middle East & Africa 
     16.5. Middle East & Africa Vascular Grafts Market Value Share Analysis, by Product 
     16.6. Middle East & Africa Vascular Grafts Market Size and Forecast, by Product 
            16.6.1. Endovascular Stent Grafts
            16.6.2. Peripheral Vascular Grafts
            16.6.3. Hemodialysis Access Grafts
            16.6.4. Bypass Grafts
            16.6.5. Others 
     16.7. Middle East & Africa Vascular Grafts Market Value Share Analysis, by Source
     16.8. Middle East & Africa Vascular Grafts Market Size and Forecast, by Source
            16.8.1. Synthetic
                     16.8.1.1. Polytetrafluethylene (PTFE)
                     16.8.1.2. Polyurethane (PU)
                     16.8.1.3. Dacron
                     16.8.1.4. Others
            16.8.2. Biological 
                     16.8.2.1. Bovine Vein
                     16.8.2.2. Saphenous Vein
                     16.8.2.3. Others
            16.8.3. Biosynthetic
                     16.8.3.1. Ovine Collagen with Polyester
                     16.8.3.2. Others
     16.9. Middle East & Africa Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft
     16.10. Middle East & Africa Vascular Grafts Market Size and Forecast, by Size of Vascular Graft
            16.10.1. Large
            16.10.2. Small
     16.11. Middle East & Africa Vascular Grafts Market Value Share Analysis, by Application
     16.12. Middle East & Africa Vascular Grafts Market Size and Forecast, by Application
            16.12.1. Coronary Artery Bypass
            16.12.2. Aneurysm
            16.12.3. Vascular Occlusion
            16.12.4. Critical Limb Ischemia
            16.12.5. Renal Failure
            16.12.6. Others
     16.13. Middle East & Africa Vascular Grafts Market Value Share Analysis, by End-user
     16.14. Middle East & Africa Vascular Grafts Market Size and Forecast, by End-user
            16.14.1. Hospitals
            16.14.2. Ambulatory Surgical Centers
            16.14.3. Cardiac Catheterization Laboratories
            16.14.4. Specialty Clinics
            16.14.5. Others 
    16.15. Middle East & Africa Vascular Grafts Market Size and Forecast, by Market Attractiveness
            16.15.1. Product 
            16.15.2. Source
            16.15.3. Size of Vascular Graft
            16.15.4. Application
            16.15.5. End-user
            16.15.6. Country/Sub-region

17. Competitive Landscape
     17.1. Company Analysis 
     17.2. Competition Matrix
     17.3. Company Profiles
            17.3.1. LaMaitre Vascular, Inc.
                     17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.3.1.2. Financial Overview 
                     17.3.1.3. Product Portfolio
                     17.3.1.4. SWOT Analysis
                     17.3.1.5. Strategic Overview
            17.3.2. B. Braun Melsungen AG 
                     17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.3.2.2. Financial Overview 
                     17.3.2.3. Product Portfolio
                     17.3.2.4. SWOT Analysis
                     17.3.2.5. Strategic Overview
            17.3.3. C. R. Bard, Inc. 
                     17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.3.3.2. Financial Overview 
                     17.3.3.3. Product Portfolio
                     17.3.3.4. SWOT Analysis
                     17.3.3.5. Strategic Overview
            17.3.4. Cook Medical
                     17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.3.4.2. Financial Overview 
                     17.3.4.3. Product Portfolio
                     17.3.4.4. SWOT Analysis
                     17.3.4.5. Strategic Overview
            17.3.5. Medtronic plc 
                     17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.3.5.2. Financial Overview 
                     17.3.5.3. Product Portfolio
                     17.3.5.4. SWOT Analysis
                     17.3.5.5. Strategic Overview
            17.3.6. ArteGrafts, Inc.
                     17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.3.6.2. Financial Overview 
                     17.3.6.3. Product Portfolio
                     17.3.6.4. SWOT Analysis
                     17.3.6.5. Strategic Overview
            17.3.7. Vascutek Ltd.
                     17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.3.7.2. Financial Overview 
                     17.3.7.3. Product Portfolio
                     17.3.7.4. SWOT Analysis
                     17.3.7.5. Strategic Overview
            17.3.8. Vascular Grafts Solution Ltd. 
                     17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.3.8.2. Financial Overview 
                     17.3.8.3. Product Portfolio
                     17.3.8.4. SWOT Analysis
                     17.3.8.5. Strategic Overview
            17.3.9. Heart Medical Europe BV 
                     17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.3.9.2. Financial Overview 
                     17.3.9.3. Product Portfolio
                     17.3.9.4. SWOT Analysis
                     17.3.9.5. Strategic Overview
            17.3.10. W. L. Gore & Associates, Inc.
                     17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.3.10.2. Financial Overview 
                     17.3.10.3. Product Portfolio
                     17.3.10.4. SWOT Analysis
                     17.3.10.5. Strategic Overview
            17.3.11. CryoLife, Inc.
                     17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.3.11.2. Financial Overview 
                     17.3.11.3. Product Portfolio
                     17.3.11.4. SWOT Analysis
                     17.3.11.5. Strategic Overview
            17.3.12. Maquet Holding B.V. & Co. KG 
                     17.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.3.12.2. Financial Overview 
                     17.3.12.3. Product Portfolio
                     17.3.12.4. SWOT Analysis
                     17.3.12.5. Strategic Overview

List of Tables 

Table 01: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Source, 2016–2026
Table 03: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Synthetic, 2016–2026
Table 04: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Biological, 2016–2026
Table 05: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Biosynthetic, 2016–2026
Table 06: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Size of Vascular Graft, 2016–2026
Table 07: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 08: Global Vascular Grafts Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 09: Global Vascular Grafts Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 10: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 11: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 12: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Source, 2016–2026
Table 13: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Synthetic, 2016–2026
Table 14: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Biological, 2016–2026
Table 15: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Biosynthetic, 2016–2026
Table 16: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2016–2026
Table 17: North America Vascular Grafts Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 18: North America Vascular Grafts Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 19: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 20: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 21: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Source, 2016–2026
Table 22: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Synthetic, 2016–2026
Table 23: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Biological, 2016–2026
Table 24: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Biosynthetic, 2016–2026
Table 25: Europe Vascular Grafts Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2016–2026
Table 26: Europe Vascular Grafts Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 27: Europe Vascular Grafts Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 28: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 29: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 30: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Source, 2016–2026
Table 31: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Synthetic, 2016–2026
Table 32: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Biological, 2016–2026
Table 33: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Biosynthetic, 2016–2026
Table 34: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2016–2026
Table 35: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 36: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 37: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 38: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 39: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Source, 2016–2026
Table 40: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Synthetic, 2016–2026
Table 41: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Biological, 2016–2026
Table 42: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Biosynthetic Source, 2016–2026
Table 43: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2016–2026
Table 44: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 45: Latin America Vascular Grafts Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 46: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 47: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 48: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Source, 2016–2026
Table 49: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Synthetic, 2016–2026
Table 50: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Biological, 2016–2026
Table 51: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Biosynthetic, 2016–2026
Table 52: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2016–2026
Table 53: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 54: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures

Figure 01: Global Vascular Grafts Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 02: Market Snapshot of Global Vascular Grafts Market 
Figure 03: Market Opportunity Map, Revenue Share, by Product 
Figure 04: Market Opportunity Map, Revenue Share, by Source
Figure 05: Market Opportunity Map, Revenue Share, by Size of Vascular Graft
Figure 06: Market Opportunity Map, Revenue Share, by Application
Figure 07: Market Opportunity Map, Revenue Share, by End-user
Figure 08: Global Vascular Grafts Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 09: Vascular Grafts Market Value Share, by Product, 2017
Figure 10: Vascular Grafts Market Value Share, by Application, 2017
Figure 11: Vascular Grafts Market Value Share, by End-user, 2017
Figure 12: Vascular Grafts Market Value Share, by Source, 2017
Figure 13: Vascular Grafts Market Value Share, by Size of Vascular Graft, 2017
Figure 14: Vascular Grafts Market Value Share, by Region, 2017
Figure 15: Global Vascular Grafts Market Value Share, by Product, 2017 and 2026
Figure 16: Global Vascular Grafts Market Attractiveness, by Product, 2018–2026
Figure 17: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Endovascular Stent Grafts, 2016–2026
Figure 18: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Peripheral Vascular Grafts, 2016–2026
Figure 19: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Hemodialysis Access Grafts, 2016–2026
Figure 20: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Bypass Grafts, 2016–2026
Figure 21: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Others, 2016–2026
Figure 22: Global Vascular Grafts Market Value Share, by Source, 2017 and 2026
Figure 23: Global Vascular Grafts Market Attractiveness, by Source, 2018–2026
Figure 24: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Synthetic, 2016–2026
Figure 25: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Biological, 2016–2026
Figure 26: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Biosynthetic, 2016–2026
Figure 27: Global Vascular Grafts Market Value Share, by Size of Vascular Graft, 2017 and 2026
Figure 28: Global Vascular Grafts Market Attractiveness, by Size of Vascular Graft, 2018–2026
Figure 29: Global Vascular Grafts Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Large, 2016–2026
Figure 30: Global Vascular Grafts Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Small, 2016–2026
Figure 31: Global Vascular Grafts Market Value Share, by Application, 2017 and 2026
Figure 32: Global Vascular Grafts Market Attractiveness, by Application, 2018–2026
Figure 33: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Coronary Artery Bypass, 2016–2026
Figure 34: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Aneurysm, 2016–2026
Figure 35: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Vascular Occlusion, 2016–2026
Figure 36: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Renal Failure, 2016–2026
Figure 37: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Critical Limb Ischemia, 2016–2026
Figure 38: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Others, 2016–2026
Figure 39: Global Vascular Grafts Market Value Share, by End-user, 2017 and 2026
Figure 40: Global Vascular Grafts Market Attractiveness, by End-user, 2018–2026
Figure 41: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Hospital, 2016–2026
Figure 42: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Ambulatory Surgical Centers, 2016–2026
Figure 43: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Cardiac Catheterization Laboratories, 2016–2026
Figure 44: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Specialty Clinics, 2016–2026
Figure 45: Global Vascular Grafts Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Others, 2016–2026
Figure 46: Global Vascular Grafts Market Value Share, by Region, 2017 and 2026
Figure 47: Global Vascular Grafts Market Attractiveness, by Region, 2018–2026
Figure 48: North America Vascular Grafts Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 49: North America Vascular Grafts Market Attractiveness, by Country, 2018–2026
Figure 50: North America Vascular Grafts Market Value Share, by Country, 2017 and 2026
Figure 51: North America Vascular Grafts Market Value Share, by Product, 2017 and 2026
Figure 52: North America Vascular Grafts Market Attractiveness, by Product, 2018–2026
Figure 53: North America Vascular Grafts Market Value Share Analysis, by Source, 2017 and 2026
Figure 54: North America Vascular Grafts Market Attractiveness, by Source, 2018–2026
Figure 55: North America Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2017 and 2026
Figure 56: North America Vascular Grafts Market Attractiveness, by Size of Vascular Graft, 2018–2026
Figure 57: North America Vascular Grafts Market Value Share, by Application, 2017 and 2026
Figure 58: North America Vascular Grafts Market Attractiveness, by Application, 2018–2026
Figure 59: North America Vascular Grafts Market Value Share, by End-user, 2017 and 2026
Figure 60: North America Vascular Grafts Market Attractiveness, by End-user, 2018–2026
Figure 61: Europe Vascular Grafts Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 62: Europe Vascular Grafts Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 63: Europe Vascular Grafts Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 64: Europe Vascular Grafts Market Value Share, by Product, 2017 and 2026
Figure 65: Europe Vascular Grafts Market Attractiveness, by Product, 2018–2026
Figure 66: Europe Vascular Grafts Market Value Share Analysis, by Source, 2017 and 2026
Figure 67: Europe Vascular Grafts Market Attractiveness, by Source, 2018–2026
Figure 68: Europe Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2017 and 2026
Figure 69: Europe Vascular Grafts Market Attractiveness, by Size of Vascular Graft, 2018–2026
Figure 70: Europe Vascular Grafts Market Value Share, by Application, 2017 and 2026
Figure 71: Europe Vascular Grafts Market Attractiveness, by Application, 2018–2026
Figure 72: Europe Vascular Grafts Market Value Share, by End-user, 2017 and 2026
Figure 73: Europe Vascular Grafts Market Attractiveness, by End-user, 2018–2026
Figure 74: Asia Pacific Vascular Grafts Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 75: Asia Pacific Vascular Grafts Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 76: Asia Pacific Vascular Grafts Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 77: Asia Pacific Vascular Grafts Market Value Share, by Product, 2017 and 2026
Figure 78: Asia Pacific Vascular Grafts Market Attractiveness,
Figure 79: Asia Pacific Vascular Grafts Market Value Share Analysis, by Source, 2017 and 2026
Figure 80: Asia Pacific Vascular Grafts Market Attractiveness, by Source, 2018–2026
Figure 81: Asia Pacific Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2017 and 2026
Figure 82: Asia Pacific Vascular Grafts Market Attractiveness, by Size of Vascular Graft, 2018–2026
Figure 83: Asia Pacific Vascular Grafts Market Value Share, by Application, 2017 and 2026
Figure 84: Asia Pacific Vascular Grafts Market Attractiveness, by Application, 2018–2026
Figure 85: Asia Pacific Vascular Grafts Market Value Share, by End-user, 2017 and 2026
Figure 86: Asia Pacific Vascular Grafts Market Attractiveness, by End-user, 2018–2026
Figure 87: Latin America Vascular Grafts Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 88: Latin America Vascular Grafts Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 89: Latin America Vascular Grafts Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 90: Latin America Vascular Grafts Market Value Share, by Product, 2017 and 2026
Figure 91: Latin America Vascular Grafts Market Attractiveness,
Figure 92: Latin America Vascular Grafts Market Value Share, by Source, 2017 and 2026
Figure 93: Latin America Vascular Grafts Market Attractiveness, by Source, 2018–2026
Figure 94: Latin America Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2017 and 2026
Figure 95: Latin America Vascular Grafts Market Attractiveness, by Size of Vascular Graft, 2018–2026
Figure 96: Latin America Vascular Grafts Market Value Share, by Application, 2017 and 2026
Figure 97: Latin America Vascular Grafts Market Attractiveness, by Application, 2018–2026
Figure 98: Latin America Vascular Grafts Market Value Share, by End-user, 2017 and 2026
Figure 99: Latin America Vascular Grafts Market Attractiveness, by End-user, 2018–2026
Figure 100: Middle East & Africa Vascular Grafts Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 101: Middle East & Africa Vascular Grafts Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 102: Middle East & Africa Vascular Grafts Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 103: Middle East & Africa Vascular Grafts Market Value Share, by Product, 2017 and 2026
Figure 104: Middle East & Africa Vascular Grafts Market Attractiveness, by Product, 2018–2026
Figure 105: Middle East & Africa Vascular Grafts Market Value Share, by Source, 2017 and 2026
Figure 106: Middle East & Africa Vascular Grafts Market Attractiveness, by Source, 2018–2026
Figure 107: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2017 and 2026
Figure 108: Middle East & Africa Vascular Grafts Market Attractiveness, by Size of Vascular Graft, 2018–2026
Figure 109: Middle East & Africa Vascular Grafts Market Value Share, by Application, 2017 and 2026
Figure 110: Middle East & Africa Vascular Grafts Market Attractiveness, by Application, 2018–2026
Figure 111: Middle East & Africa Vascular Grafts Market Value Share, by End-user, 2017 and 2026
Figure 112: Middle East & Africa Vascular Grafts Market Attractiveness, by End-user, 2018–2026

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Vascular Grafts Market